Evidence map›Paper›PMID 37408187›Full record

ArticleCells2023

Live Cell Imaging of ATP Levels Reveals Metabolic Compartmentalization within Motoneurons and Early Metabolic Changes in

Vitaly L Zimyanin, Anna-Maria Pielka, Hannes Glaß, Julia Japtok, Dajana Großmann, Melanie Martin, Andreas Deussen, Barbara Szewczyk, Chris Deppmann, Eli Zunder and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Vitaly L ZimyaninDepartment of Molecular Physiology and Biological Physics, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.ORCID 0000-0001-8601-4451
Anna-Maria PielkaTranslational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.
Hannes GlaßTranslational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.ORCID 0000-0003-3155-5300
Julia JaptokDepartment of Neurology, Technische Universität Dresden, 01307 Dresden, Germany.
Dajana GroßmannTranslational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.
Melanie MartinInstitute of Physiology, Technische Universität Dresden, 01307 Dresden, Germany.
Andreas DeussenInstitute of Physiology, Technische Universität Dresden, 01307 Dresden, Germany.
Barbara SzewczykTranslational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.
Chris DeppmannDepartment of Biology, Graduate School of Arts and Sciences, University of Virginia, Charlottesville, VA 22902, USA.
Eli ZunderDepartment of Biomedical Engineering, School of Medicine, University of Virginia, Charlottesville, VA 22902, USA.
Peter M AndersenDepartment of Clinical Sciences, Neurosciences, Umeå University, SE-901 85 Umeå, Sweden.
Tobias M BoeckersDeutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm Site, 89081 Ulm, Germany.
Jared SterneckertCentre for Regenerative Therapie, Technische Universität Dresden, 01307 Dresden, Germany.
Stefanie RedemannDepartment of Molecular Physiology and Biological Physics, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
Alexander StorchDeutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, 18147 Rostock, Germany.
Andreas HermannTranslational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.ORCID 0000-0002-7364-7791
University of Rostock · DEUniversity of Virginia · USTechnische Universität Dresden · DEGerman Center for Neurodegenerative Diseases · DEUmeå University · SEUniversität Ulm · DEUniversity Hospital Carl Gustav Carus · DE

Funding

Extrinsic Mechanisms Governing Injury-Induced Axon DegenerationR01NS091617 · NINDS · UNIVERSITY OF VIRGINIA · PI DEPPMANN, CHRISTOPHER D · 2015 to 2025
$4.0M
Deciphering Trophic Signaling Programs Governing Peripheral Sensory Nervous System DevelopmentR01NS111220 · NINDS · UNIVERSITY OF VIRGINIA · PI ZUNDER, ELI · 2020 to 2024
$2.6M
High-speed and high-resolution Zeiss880 multiphoton microscopy systemS10OD025156 · OD · UNIVERSITY OF VIRGINIA · PI PERIASAMY, AMMASI · 2019 to 2019
$600k
NIH HHS S10 OD025156NINDS NIH HHS R01 NS091617NINDS NIH HHS R01 NS111220
6 · The paper itself

Abstract

Motoneurons are one of the most energy-demanding cell types and a primary target in Amyotrophic lateral sclerosis (ALS), a debilitating and lethal neurodegenerative disorder without currently available effective treatments. Disruption of mitochondrial ultrastructure, transport, and metabolism is a commonly reported phenotype in ALS models and can critically affect survival and the proper function of motor neurons. However, how changes in metabolic rates contribute to ALS progression is not fully understood yet. Here, we utilize hiPCS-derived motoneuron cultures and live imaging quantitative techniques to evaluate metabolic rates in fused in sarcoma (FUS)-ALS model cells. We show that differentiation and maturation of motoneurons are accompanied by an overall upregulation of mitochondrial components and a significant increase in metabolic rates that correspond to their high energy-demanding state. Detailed compartment-specific live measurements using a fluorescent ATP sensor and FLIM imaging show significantly lower levels of ATP in the somas of cells carrying FUS-ALS mutations. These changes lead to the increased vulnerability of diseased motoneurons to further metabolic challenges with mitochondrial inhibitors and could be due to the disruption of mitochondrial inner membrane integrity and an increase in its proton leakage. Furthermore, our measurements demonstrate heterogeneity between axonal and somatic compartments, with lower relative levels of ATP in axons. Our observations strongly support the hypothesis that mutated FUS impacts the metabolic states of motoneurons and makes them more susceptible to further neurodegenerative mechanisms.

Indexed as

Amyotrophic Lateral SclerosisAdenosine TriphosphateHumansMitochondriaMotor NeuronsMutationRNA-Binding Protein FUSAdenosine TriphosphateFUS protein, humanRNA-Binding Protein FUSamyotrophic lateral sclerosismetabolismmitochondria

Identifiers

PMID37408187
PMCPMC10216752
OpenAlexW4376115262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.